This study investigated the incidence of retinopathy of prematurity (ROP) and its risk factors in a tertiary referral hospital in Taiwan to evaluate the applicability of the ROP screening guidelines ). A pediatric ophthalmologist applied the 2006 guidelines to screen for ROP and to treat with laser photocoagulation in each case. We retrieved all records of premature infants referred for ROP screening at the hospital during 2004 to 2008. Univariate logistic regression analysis was applied firstly to identify factors correlating with stage 3 ROP or with laser treatment, and then those significant (p < 0.05) risk factors were analyzed by multivariate logistic regression. In the 138 male and 118 female premature infants in this study, mean gestation age was 30.8 AE 2.8 weeks, and mean birth weight was 1464.7 AE 434.2 g. The percentage of infants with ROP in at least one eye was 38.7%. Thirty two (12.5%) had ROP stage 3 or higher in at least one eye. Multivariate logistic regression analysis showed that the best predictors of type 1 pre-threshold ROP (requiring laser treatment) were young gestational age, low birth weight and male gender. As medical care of extremely premature infants improves, timely identification and treatment of conditions such as ROP are essential.
Introduction
Retinopathy of prematurity (ROP), a proliferative retinal vascular disease in premature infants, can cause visual impairment and even blindness [1, 2] . The disease is also a leading cause of blindness in early childhood [3] . As survival of premature infants with very low birth weight improves, the incidence of ROP has increased. In the CRYO-ROP study, treatment of the threshold disease (at least 5 contiguous or 8 cumulative clock hours of Stage 3 ROP in zone I or II with plus disease) can decrease the risk of retinal detachment and blindness [4] . The ROP screening guidelines published by the American Academy of Pediatrics, American Academy of Ophthalmology, and American Association for Pediatric Ophthalmology and Strabismus in 2006 (2006 guidelines) indicate that, for optimal outcome, ROP should be treated early (at type 1 pre-threshold ROP) rather than waiting until development of the threshold disease [5, 6] . The 2006 guidelines recommend initiating treatment in cases of type 1 pre-threshold ROP (or high risk pre-threshold ROP), including cases of: (1) any Stage of ROP in zone I with plus disease; (2) Stage 3 ROP in zone I; (3) Stage 2 or 3 ROP in zone II with plus disease [5, 6] . Hospital/neonatal intensive care unit-specific criteria such as birth weight (BW) and gestational age (GA) have also been recommended for ROP screening, especially in developing countries [5] . The site of this study was a 15bed neonatal intensive care unit (NICU) in a southern Taiwan tertiary referral hospital. The ROP screening criteria applied at this NICU reflected the 2006 guidelines with one exception: infants with BW higher than 2000 g were still referred for ROP screening if they had an unstable clinical course requiring oxygen therapy. To obtain the current ROP data needed to establish unitspecific screening guidelines, this study explored the incidence of ROP, its risk factors, and the applicability of the 2006 guidelines at this facility.
Methods
This retrospective review of records was approved by the Institutional Review Board of Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. All premature infants enrolled were screened by a single pediatric ophthalmologist (YHL). Data collection included gender, GA, BW, age of mother, concurrent systemic diseases/conditions, days on oxygen therapy, worst ROP status, and/or laser treatment. The standard of care in the NICU did not significantly change during the study period (years 2004e2008). In each premature infant, the need for ophthalmologist consultation was determined by the neonatologists. The criteria for ophthalmic consultation for the premature infants enrolled were any unstable clinical course requiring high supplemental oxygen. The International Classification of Retinopathy of Prematurity was used for ROP staging [7e9]. Laser photocoagulation was performed by the pediatric ophthalmologist according to indications for early treatment of ROP specified by the 2003 and 2006 ROP screening guidelines [5, 6] . Continuous variables were presented as means, and standard deviation (SD) and categorical variables were expressed as numbers and percentages, respectively. Statistical analyses were performed using SPSS for Windows version 17.0 (SPSS Inc., Chicago, IL, USA). Univariate logistic regression analysis was used to identify risk factors correlating with Stage 3 ROP or with the need for laser treatment. Significant (p < 0.05) risk factors were then analyzed by multivariate logistic regression.
Results
Of the 261 premature infants screened by the pediatric ophthalmologist, five were excluded due to incomplete medical records (one without GA data, three without systemic data, and one without initial retinal examination data). The analysis therefore included 256 (98.1%) of the 261 premature infants screened.
Demographic data
In the 256 infants enrolled (138 male, 118 female), average GA was 30.8 AE 2.8 weeks (95% CI, 30.5e31.2 weeks; range 24.3e38.1 weeks). The GA was 28 weeks in 49 (19.1%; 95% CI, 14.3e24.0%) and 30 weeks in 100 (39.1%; 95% CI, 33.1e45.1%). Mean BW was 1464.7 AE 434.2 g (95% CI, 1411.3e1518.2 g; range 541e3250 g). About half (53.1%) of the infants were 1500 g (95% CI, 47.0e59.3%), and 233 (91.0%) were 2000 g (95% CI, 87.5e94.5%). Singleton, twins and triplets comprised 71.4%, 25.9% and 1.2%, respectively. More than half (56.4%) were outborn (95% CI, 50.0e62.8%). Table 1 shows the GA and BW data for infants in different stages of ROP and for those who required laser treatment. Three infants died of respiratory failure. One infant (male, GA Z 26.1 weeks, BW Z 940 g) had sepsis shock, pneumonia, intraventricular hemorrhage (IVH), respiratory distress syndrome (RDS), and chronic lung diseases; another infant (male, GA Z 25.3 weeks, and BW Z 670 g) had pneumonia, disseminated intravascular coagulation (DIC), necrotizing enterocolitis, IVH, hydrocephalus, and RDS. Both of these infants, however, showed regression of ROP after laser photocoagulation. The third infant (female, GA Z 33.4 weeks, and BW Z 1940 g), who did not have ROP, died of heart failure, renal failure, DIC, ascites, pneumonia, fungiemia, and sepsis shock.
Stage 3 ROP or worse
The percentage of infants with ROP in at least one eye was 38.7% (95% CI, 32.7e44.7%). Thirty-two (12.5%) had ROP Stage 3 or higher in at least one eye (95% CI, 8.4e16.6%). Stage 3 was noted in the right and left eyes of 10.2% (95% CI, 6.4e13.9%) and 11.3% (95% CI, 7.4e15.2%), which was not a significant difference. The 32 infants in Stage 3 had a mean GA of 27.6 (AE 2.3) weeks and a mean BW of 1002.9 (AE 250.7) g. The male-to-female ratio was 1.9 (21:11). Of the infants with Stage 3 ROP, all except one weighed 1500 g (1620 g). In infants with BW 1000 g, BW 1001e1500 g, and BW 1501e2000 g, 41.5% (n Z 17), 13 
Laser photocoagulation
Seventeen infants required laser photocoagulation in both eyes (6.6%; 95% CI, 3.6e9.7%), and all were < 1500 g. Mean GA was 26.5 (AE 1.3) weeks, and mean BW was 886.2 (AE 145.5) g. The male-to-female ratio was 4.7 (14:3) . In all seventeen patients, ROP regressed after laser photocoagulation, and no adverse events occurred. Only half of the Stage 3 ROP patients (16 of the 32) required laser treatment, while one patient without Stage 3 ROP fulfilled the treatment indication. Of 41 infants with BW 1000 g, twelve (29.3%) had received laser treatment. Of 95 with BW of 1001e1500 g, five (5.3%) had received laser treatment (BWs Z 1020 g, 1060 g, 1090 g, 1100 g, and 1114 g, respectively). In all patients who had received laser treatment, GA was 30 weeks. Of the twenty-nine with GA 28 weeks, 14 (28.6%) had received laser treatment. Of the 51 infants with GA 29e30 weeks, three (5.9%) had received laser treatment. Table 1 shows other relevant data.
Logistic analysis
Univariate logistic analysis showed that GA, BW, patent ductus arteriosus (PDA), anemia, IVH, and days on oxygen therapy were associated with Stage 3 ROP (Table 2) . However, multivariate logistic analysis by the stepwise (likelihood ratio) method showed that only GA was significantly associated with Stage 3 ROP. Univariate logistic analysis showed that GA, BW, PDA, anemia, IVH, and days on oxygen therapy were associated with the need for laser treatment (Table 3 ). Multivariate logistic analysis by the stepwise (likelihood ratio) method showed that GA, BW, and male gender (a positive risk factor) were significantly associated with the need for laser therapy. Tables 2and 3 show the detailed data related to characteristics of patients' systemic diseases/conditions and ages of the mother that were associated with Stage 3 ROP or with the need for laser treatment. Table 4 shows that mean GA was 0.7 weeks younger in males than in females. Table 4 shows other data regarding gender analysis. Table 1 shows that the 2006 guidelines are suitable for screening neonates at this institution. All infants who needed laser treatment weighed 2000 g or less. Although four (2.6%) infants with GA > 30 weeks had Stage 3 ROP, none met the criteria for laser treatment. The incidence of ROP in this institute was comparable to that in Saudi Arabia (61.4% for GA 29e32 weeks) and in Turkey (49.4% for BW < 1250 g) [10, 11] but was higher than that in Sweden (55.6% for GA Z 26 weeks) and in USA (7.75% for GA 29e30 weeks) [12, 13] . Further study of ROP morbidity in the 49 infants with GA 28 weeks showed that 41 (83.7%) had ROP. Of these, 22 (53.7%) had Stage 3 ROP, and 14 (34.1%) required laser treatment. In the 41 infants with BW 1000 g, 33 (80.5%) had ROP. Of these, 18 (54.5%) had Multivariate logistic regression analysis showed that GA was the only significant predictor for Stage 3 ROP. Although many studies have confirmed that both GA and BW are risk factors for ROP, none have analyzed risk factors for severe ROP [14] . Not all patients with ROP develop type 1 prethreshold ROP, which requires laser treatment. The finding that GA was a stronger predictor compared to BW is reasonable as data for infants at a young GA may interfere with the statistical results.
Discussion
The average GA was significantly younger (by about 4.9 days) in the male infants than in the female infants in this study. However, systemic disease was not gender-related. Interestingly, multivariate logistic regression analysis showed that male gender was a risk factor for type 1 prethreshold ROP, which requires laser treatment, but not for Stage 3 ROP. In twin pregnancy, male gender in one or both twins is a risk factor for preterm delivery [15] . Systemic morbidity is also reportedly more common in infant males [16] . Both this and the above studies agree that premature males are susceptible to ROP and systemic morbidity. However, further studies are needed to clarify the precise mechanism of this susceptibility. Although poor post-natal weight gain is reportedly a risk factor for severe ROP [17] , the current study revealed no significant correlation. As infants with severe ROP tended to have low body weight and relatively worse clinical conditions, BW may have confounded post-natal weight gain. Whereas older maternal age is another reported risk factor for ROP [18] , the current study again revealed no correlation. Unlike the studies cited above, this study analyzed relatively more severe stages of ROP (Stage 3 ROP and type 1 pre-threshold ROP). The results of this study suggest that maternal age may be related to ROP but not to severe ROP. Another possibility is that the age of the mother correlates positively with premature birth, i.e., premature birth is more common in older mothers than in younger mothers [19] .
In conclusion, the 2006 guidelines are suitable for screening premature infants for ROP at this neonatal intensive care unit. The recommended screening criteria in this institute were any infants with GA < 31 weeks or BW 1500 g, or selected infants with BW of 1500e2000 g or GA > 30 weeks with an unstable clinical course. In this population, low BW, young GA, and male gender are risk factors for laser treatment. As advances in pediatric care improve survival in extremely premature infants and as treatment for the most advanced stages of ROP require an increasingly specialized workforce and precision instruments, NICUs in this and other hospitals must prepare to manage growing numbers of premature infants with severe and complicated ROP. Therefore, in addition to recruiting and training qualified personnel for managing complicated ROP, hospitals must prepare by acquiring the facilities and equipment needed for treating this condition.
